Morag Peberdy advises clients on intellectual property issues in Europe, including patents, trade marks, designs, copyright, database rights and confidential information. Ms. Peberdy is a qualified solicitor advocate, allowing her to represent clients at the highest level of English litigation. She has successfully litigated patent, trade mark and trade secret cases in the High Court. She regularly advises on contractual disputes, for example over the terms of R&D agreements, and acted for the winning party in one of the highest profile English disputes concerning a patent licence.
Ms. Peberdy advises clients on the intellectual property issues arising in corporate transactions, including mergers and acquisitions, initial public offerings, venture capital investments, and restructurings. Ms. Peberdy also drafts a range of intellectual property agreements including technology transfers, intellectual property pipeline arrangements, licensing and joint ventures. Ms. Peberdy’s insight into both contentious and non-contentious IP matters enables her to bring a valuable perspective and breadth of knowledge to strategic intellectual property issues, which is invaluable in assisting clients’ intellectual property law reform efforts.
Ms. Peberdy has a background in biological sciences and she particularly enjoys working with clients in the life science sector. Ms. Peberdy has been a member of the Intellectual Property Advisory Committee of the BioIndustry Association for over a decade, advising across the spectrum of intellectual property issues which impact on bioscience enterprises in the UK.
- Laboratorios Esteve, S.A. in a global multi-programme discovery and development collaboration with Mundipharma Laboratories GmbH and Purdue Pharmaceuticals LP to bring to market important next generation products for the management of pain.
- A luxury goods company on trademark and copyright litigation in the UK and Belgium.
- Cambridge Antibody Technology in its successful English court litigation over royalties in relation to sales of the monoclonal antibody product Humira.
- Securing the in-licensing of patent and know-how rights to two UK spin-out companies in the fields of rheumatology, and anti-inflammatory and anti-cancer therapy.
- A large US pharmaceutical company in a English court action involving a patent licence agreement relating to antibody technology.
- Advising on IP diligence, reps and warranties, and preparing IP agreements for a complex medical device M&A transaction.
- Multi-jurisdictional trade mark licensing for an international consumer goods company.
- The interpretation of patent licence and R & D agreements relating to various life science technologies for a major UK research body.
- The British Horseracing Authority on the reorganization of the British horseracing industry and exploitation of the database of British horseracing.
Honors and Rankings
- Euromoney Legal Media Group, shortlisted for Europe Women in Business Law Awards for Patent (2014)
- IAM Patent 1000 - The World’s Leading Patent Practitioners (2014)
- Super Lawyers - London, Intellectual Property Law (2013)
- Legal 500 UK
- Pharmaceuticals & Biotech (2012-2014)
- IP (2011-2013)
- PLC Which Lawyer? Intellectual Property: Commercial IP, England (2011-2012)
- Chair of pro bono activities in the London office.
- Barnardo’s (the UK’s leading children’s charity) on a range of intellectual property issues.
- An individual client, referred by LawWorks, to successfully resolve a UK copyright action.
Memberships and Affiliations
- UK BioIndustry Association Intellectual Property Advisory Committee
- Licensing Executive Society (LES)
- International Association for the Protection of Intellectual Property (AIPPI)
- The Intellectual Property Lawyers Organisation (TIPLO)
Publications and Speeches
- "Intellectual Property Strategies & Considerations for Initial Commercialisation Planning," NanoEntrepreneurs Workshop "What does it take to commercialise micro & nanoscale research & development? (1/28/2014)
- "IP Licensing and Insolvency," UK AIPPI Working Group's response to Q241 (2014), Co-Author
- "The New Unitary Patent for Europe: A Short Overview," European Chamber of Commerce in Korea (ECCK) (July 2013), Author